Home
Biovac

Biovac Market Share Analysis for November 2025

To be the leading biopharmaceutical company in Africa, committed to protecting life through the development, end-to-end manufacture & global supply of vaccines and other biologicals. OUR VALU…

Health > Biotechnology and Pharmaceuticals

Domainbiovac.co.za

Year Founded2003

Employees201 - 500

Annual Revenue$15M - $25M

Biovac

Biovac (including company regionals)

biovac.co.za

See more website traffic and engagement information

Biovac Revenue up to November 2025 is 15M - 25M

revenue generated by Biovac top domains

Biovac top domains revenue over 3 years

Revenue for Biovac top domains

biovac.co.za15M - 25M

See more with Sales Intelligence

Total visits to Biovac's top domains

Understand Biovac market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biovac.co.za16.1K

See more with Sales Intelligence

Avg. visit duration in Biovac's top domains

Analyze Biovac engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biovac.co.za00:00:50

See more with Sales Intelligence

Avg. pageviews on Biovac's top domains

See how Biovac keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biovac.co.za2.90

See more with Sales Intelligence

Biovac top competitors by domain

Top similar sites in November 2025, ranked by their affinity

roche.co.zaCompany NameRocheEmployees> 10001HQSwitzerlandAnnual revenue> $1BTotal visits9.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Biovac

These are the website technologies, by industry, used by Biovac top domains

Social (3)

Instagram

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

7

See all

News & Signals from Biovac

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiovac launches cholera vaccine clinical trial.Biovac, a South African biopharmaceutical company and client of the International Finance Corporation (IFC), has launched clinical trials for the country's first locally developed oral cholera vaccine - marking a significant milestone for Africa's vaccine manufacturing landscape.

NewsBiovac launches state-of-the-art product development laboratory.Biovac, a leading South African biopharmaceutical company, is launching a state-of-the-art product development laboratory at its Cape Town facility, to expand the company's ability to develop vaccines and other therapeutics.

NewsBiovac expands facilities to Cape Town, South Africa.The project primarily focused on Biovac's state-of-the-art vaccine manufacturing facility in Cape Town, which aims to scale up vaccine production to meet global standards.